Invention Grant
- Patent Title: Isotopologues of 2-(tert butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide
-
Application No.: US16452691Application Date: 2019-06-26
-
Publication No.: US10689351B2Publication Date: 2020-06-23
- Inventor: Hon-Wah Man , Mohit Atul Kothare
- Applicant: Signal Pharmaceuticals, LLC
- Applicant Address: US CA San Diego
- Assignee: Signal Pharmaceuticals, LLC
- Current Assignee: Signal Pharmaceuticals, LLC
- Current Assignee Address: US CA San Diego
- Agency: Jones Day
- Main IPC: C07D239/48
- IPC: C07D239/48 ; C07B59/00
Abstract:
Provided herein are isotopologues of Compound A, which are enriched with isotopes such as, for example, deuterium. Pharmaceutical compositions comprising the isotope-enriched compounds, and methods of using such compounds are also provided.
Public/Granted literature
Information query
